Radio and PodcastRadio and PodcastLive Radio & Podcasts
Amber Luong, MD, PhD, FACS - Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes artwork
Science & Medicine

Amber Luong, MD, PhD, FACS - Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes

PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast by PeerView, 24 West 40th Street, Suite 950, New York, NY 10018

Apr 27, 202600:51:51Science & Medicine

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Pra...

About This Episode

Amber Luong, MD, PhD, FACS - Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes is an episode from PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast by PeerV...

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Apr 27, 2026, 00:51:51 long, audio available.

Questions About This Episode

What is Amber Luong, MD, PhD, FACS - Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes about?

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PRZ865. CME/MOC/CC/AAPA/IPCE credit will be available until April 20, 2027. Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi. Disclosure information is available at the beginning of the video presentation.

Where can I listen to Amber Luong, MD, PhD, FACS - Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes?

You can listen to Amber Luong, MD, PhD, FACS - Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes online on Radio and Podcast. Open the player on this page to stream the available audio.

Which podcast is Amber Luong, MD, PhD, FACS - Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes from?

Amber Luong, MD, PhD, FACS - Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes is an episode from PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast by PeerView, 24 West 40th Street, Suite 950, New York, NY 10018.

How long is this episode?

This episode is 00:51:51 long.

When was this episode published?

This episode was published on Apr 27, 2026.

Can I save Amber Luong, MD, PhD, FACS - Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes for later?

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Are there related episodes from PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast?

Yes. This page shows related episodes from PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast when more episodes are available from the podcast feed.

Quick Answers About This Episode

Where can I listen to Amber Luong, MD, PhD, FACS - Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes?

You can listen to Amber Luong, MD, PhD, FACS - Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes on this page when the episode audio is available from the podcast feed.

Which podcast is this episode from?

Amber Luong, MD, PhD, FACS - Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes is from PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast by PeerView, 24 West 40th Street, Suite 950, New York, NY 10018.

What are the episode details?

Published Apr 27, 2026 and 00:51:51 long